LARA SANDERS: Open Payments
NPI 1508252644 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 16 payments from 12 companies in 2025. Trend: 2023 $141 · 2024 $885 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 1 | $126 |
| Vanda Pharmaceuticals Inc. | 1 | $124 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Abbott Laboratories | 2 | $45 |
| CVRx, Inc. | 1 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| SHIELD THERAPEUTICS INC | 1 | $29 |
| ABBVIE INC. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| ABIOMED | 1 | $18 |
Products named: Qelbree, FANAPT, TRELEGY ELLIPTA, Barostim Neo System, AIRSUPRA, ACCRUFER, QULIPTA, NUZYRA.
Industry payments across AR — which companies pay providers there.
